Cargando…
Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids
Although the overall survival in pediatric rhabdomyosarcoma (RMS) has increased over the last decades, the most aggressive subtype of alveolar RMS is in dire need of novel treatment strategies. RMS cells evade cell death induction and immune control by increasing the expression of inhibitors of apop...
Autores principales: | Särchen, Vinzenz, Reindl, Lisa Marie, Wiedemann, Sara, Shanmugalingam, Senthan, Bukur, Thomas, Becker, Julia, Suchan, Martin, Ullrich, Evelyn, Vogler, Meike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047333/ https://www.ncbi.nlm.nih.gov/pubmed/36980247 http://dx.doi.org/10.3390/cells12060906 |
Ejemplares similares
-
Unleashing the power of NK cells in anticancer immunotherapy
por: Vogler, Meike, et al.
Publicado: (2021) -
Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy
por: Särchen, Vinzenz, et al.
Publicado: (2022) -
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells
por: Fischer, Kyra, et al.
Publicado: (2017) -
Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy
por: Wendel, Philipp, et al.
Publicado: (2021) -
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
por: Ullrich, Evelyn, et al.
Publicado: (2022)